中文 | English
Return
Total: 4481 , 1/449
Show Home Prev Next End page: GO
Author:(Xin-xin ZHOU)

1.How to Protect the Vulnerable Groups in Drug Clinical Trials

Xin LIN ; Xin ZHOU

Chinese Medical Ethics 2017;30(5):572-575

2.Study on in vitro models of drug absorption

Xin ZHOU

Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-

3.Research on etiology and drug resistance analysis of ICU ventilator-associated pneumonia

Xin ZHOU

China Medical Equipment 2016;13(1):111-113

4.Expression and clinical significance of p73? in breast carcinoma tissues

Xin ZHOU

Journal of Chongqing Medical University 1986;0(04):-

6.Validity of asthma control test questionnaire at primary-care settings in China

Fengming DING ; Xin ZHOU

Chinese Journal of General Practitioners 2009;8(9):628-630

7.Analysis of the Use of Narcotic Analgetics in Our Hospital During 2005~2007

Jian SHEN ; Xin ZHOU

China Pharmacy 2005;0(20):-

8.Research progress of Bruton tyrosine kinase inhibitors in mantle cell lymphoma

Xiangxiang ZHOU ; Xin WANG

Journal of Leukemia & Lymphoma 2016;25(6):377-380

9.Clinical value of hippocampal gyrus protection in whole brain radiotherapy

Xin DONG ; Zongmei ZHOU

Chinese Journal of Radiation Oncology 2016;25(5):526-529

10.Research progress for aberrant crypt foci

Xin ZHOU ; Dazheng WU

Chinese Pharmacological Bulletin 1986;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4481 , 1/449 Show Home Prev Next End page: GO